BRUSSELS, Nov 21 (Reuters) - EU antitrust regulators
will decide by Dec. 22 whether to clear Swedish private equity
group EQT's 4.46 billion pound ($5.6 billion) takeover bid for
British veterinary pharmaceuticals maker Dechra Pharmaceuticals
DPH.L , according to a European Commission filing.
EQT announced the cash acquisition in June, making it one of
the biggest deals in the UK private equity sector this year.
EQT sought approval from the EU competition enforcer on Nov.
17.
The Commission can either clear the deal with or without
remedies after its preliminary review or it can open a
four-month long investigation if it has serious concerns.
($1 = 0.8025 pounds)
(Reporting by Foo Yun Chee, Editing by Louise Heavens)
((foo.yunchee@thomsonreuters.com; +32 2 585 2866; Reuters
Messaging: foo.yunchee.thomsonreuters.com@reuters.net))